Increased Dosage : 0.5 mg for at least another four weeks if needed
Newly released survey data revealed the following key trends for GLP-1 drug coverage: 51% of employers provide coverage for diabetes only (a decrease from 56% in 2025 and 66% in 2024) 37% provide coverage for both diabetes and weight loss (on the rise from 31% in 2025 and 17% in 2024) 12% cover GLP-1 drugs for other conditions (sleep apnea, cardiovascular disease, etc.)
Soluble fibre is found in oats, chia seeds, lentils, apples and berries, which absorbs water and forms a gel-like substance that softens stool
It lowers blood glucose and increases insulin sensitivity, thereby reducing insulin resistance
Dixon, Use of Glucagon-Like Peptide-1 Agonists and Increased Risk of Procedural Sedation and Endotracheal Intubation in the Emergency Department, Ann